The literature showed that rs11571316 may increase the susceptibility of cervical cancer by increasing the expression level of the CTLA4 (40); we indicated that rs11571316 involved in RA pathogenesis and inflammatory response may result from upregulating the CTLA4 expression. This evidence concerns the gene CTLA4 and rheumatoid arthritis.